EUVIMEDEUVIMED entdecken
Crossref

Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma

Akihisa Ohno, Nao Fujimori, Kazuhide Matsumoto, Shojiro Haji, Osamu Sugahara, Ayumu Takeno, Takeo Yamamoto, Akihiko Suenaga, Shotaro Kakehashi, Takahiro Ueda, Masatoshi Murakami, Katsuhito Teramatsu und 5 weitere

Oncogene · 2026

DOI: 10.1038/s41388-025-03633-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncogene, 2026. Verfasst von Akihisa Ohno und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Membrane Glycoproteins. Die Arbeit nennt 51 Literaturangaben. Gefördert von: Mochida Memorial Foundation for Medical and Pharmaceutical Research, Daiwa Securities Health Foundation, MEXT | Japan Society for the Promotion of Science (JSPS).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic ductal adenocarcinoma (PDAC) has two subtypes: the "classical/progenitor" type and "basal-like/squamous" type, the latter of which has poor clinical outcomes with no effective treatment strategies. We aimed to elucidate the role of epithelial membrane protein 1 (EMP1) in PDAC and its potential as a therapeutic target, particularly in aggressive disease such as "basal-like/squamous" type of PDAC. We examined the association of EMP1 expression using patient-derived organoids (PDOs) of human PDAC, K-RASLSL-G12D, Trp 53LSL-R172H, and Pdx1-Cre recombinase mice, human PDAC cell lines, and publicly available clinical datasets. The functional roles of EMP1 were evaluated in vitro and in vivo through its knockout and stable overexpression. EMP1 knockout reduced proliferation, metastasis, and drug resistance, whereas overexpression enhanced malignant features. Transcriptomic analysis revealed that EMP1 promotes epithelial-mesenchymal transition (EMT), extracellular matrix remodeling, and the K-RAS signaling pathway. EMP1 expression is inversely implicated in the oxidative phosphorylation pathway, which is characteristic of the "classical/progenitor" type. Furthermore, integrated analysis revealed an association between EMP1 expression and ERK phosphorylation. EMP1 plays a crucial role in the pathogenesis of PDAC, as it contributes to the proliferative and metastatic characteristics of PDAC. This study suggests that EMP1 may be a potential therapeutic target gene for aggressive disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Pancreatic DuctalPancreatic NeoplasmsMembrane GlycoproteinsHumansAnimalsMiceEpithelial-Mesenchymal TransitionCell Line, TumorCell ProliferationGene Expression Regulation, NeoplasticNeoplasm ProteinsReceptors, Cell Surface

Substanzen

epithelial membrane protein-1Membrane GlycoproteinsNeoplasm ProteinsReceptors, Cell Surface

Autor:innen und Institutionen

  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. fujimori.nao.239@m.kyushu-u.ac.jp.
  • Anticancer Strategies Laboratory, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
  • Department of Medicine and Bioregulatory Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan. ogawa.yoshihiro.828@m.kyushu-u.ac.jp.

Förderung

  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • Daiwa Securities Health Foundation
  • MEXT | Japan Society for the Promotion of Science (JSPS)

Zitieren

APA

Ohno, A., Fujimori, N., Matsumoto, K., Haji, S., Sugahara, O., Takeno, A., Yamamoto, T., Suenaga, A., Kakehashi, S., Ueda, T., Murakami, M., Teramatsu, K., Ueda, K., Oono, T., Oda, Y., Nakayama, K. I., & Ogawa, Y. (2026). Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Oncogene. https://doi.org/10.1038/s41388-025-03633-4

Vancouver

Ohno A, Fujimori N, Matsumoto K, Haji S, Sugahara O, Takeno A, et al. Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma. Oncogene. 2026. doi:10.1038/s41388-025-03633-4

BibTeX
@article{Ohno2026,
  author = {Ohno, Akihisa and Fujimori, Nao and Matsumoto, Kazuhide and Haji, Shojiro and Sugahara, Osamu and Takeno, Ayumu and Yamamoto, Takeo and Suenaga, Akihiko and Kakehashi, Shotaro and Ueda, Takahiro and Murakami, Masatoshi and Teramatsu, Katsuhito and Ueda, Keijiro and Oono, Takamasa and Oda, Yoshinao and Nakayama, Keiichi I and Ogawa, Yoshihiro},
  title = {Role of a transmembrane protein, epithelial membrane protein 1, in the pathogenesis of pancreatic ductal adenocarcinoma},
  journal = {Oncogene},
  year = {2026},
  doi = {10.1038/s41388-025-03633-4}
}
Kostenlos starten →